JP4150435B2 - アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤 - Google Patents

アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤 Download PDF

Info

Publication number
JP4150435B2
JP4150435B2 JP01205697A JP1205697A JP4150435B2 JP 4150435 B2 JP4150435 B2 JP 4150435B2 JP 01205697 A JP01205697 A JP 01205697A JP 1205697 A JP1205697 A JP 1205697A JP 4150435 B2 JP4150435 B2 JP 4150435B2
Authority
JP
Japan
Prior art keywords
group
chemical formula
acid
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP01205697A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10152471A5 (enExample
JPH10152471A (ja
Inventor
親生 西野
文孝 佐藤
智宏 植竹
宏忠 福西
称央 小島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP01205697A priority Critical patent/JP4150435B2/ja
Priority to TW086104833A priority patent/TW399044B/zh
Priority to US08/842,891 priority patent/US5814634A/en
Priority to CA002202958A priority patent/CA2202958A1/en
Priority to KR1019970015041A priority patent/KR19980069747A/ko
Priority to AT97302666T priority patent/ATE204867T1/de
Priority to DE69706355T priority patent/DE69706355T2/de
Priority to EP97302666A priority patent/EP0802196B1/en
Priority to AU18987/97A priority patent/AU711954C/en
Publication of JPH10152471A publication Critical patent/JPH10152471A/ja
Publication of JPH10152471A5 publication Critical patent/JPH10152471A5/ja
Application granted granted Critical
Publication of JP4150435B2 publication Critical patent/JP4150435B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP01205697A 1996-04-18 1997-01-06 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤 Expired - Fee Related JP4150435B2 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP01205697A JP4150435B2 (ja) 1996-04-18 1997-01-06 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
TW086104833A TW399044B (en) 1996-04-18 1997-04-15 Alkyleneamine derivative, anti-ulcer agent and antibacterial agent
CA002202958A CA2202958A1 (en) 1996-04-18 1997-04-17 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug
US08/842,891 US5814634A (en) 1996-04-18 1997-04-17 Alkylenediamine derivative anti-ulcer drug and antibacterial drug
AT97302666T ATE204867T1 (de) 1996-04-18 1997-04-18 Alkylendiamin-derivate als arzneimittel zur behandlung von geschwüren und hemmung von helicobacter pylori
DE69706355T DE69706355T2 (de) 1996-04-18 1997-04-18 Alkylendiamin-Derivate als Arzneimittel zur Behandlung von Geschwüren und Hemmung von Helicobacter pylori
KR1019970015041A KR19980069747A (ko) 1996-04-18 1997-04-18 알킬렌디아민 유도체 및 항궤양제, 항균제
EP97302666A EP0802196B1 (en) 1996-04-18 1997-04-18 Alkylenediamine derivatives as drugs for the treatment of ulcers and the inhibition of Helicobacter pylori
AU18987/97A AU711954C (en) 1996-04-18 1997-04-18 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP12219596 1996-04-18
JP8-122195 1996-09-30
JP27887196 1996-09-30
JP8-278871 1996-09-30
JP01205697A JP4150435B2 (ja) 1996-04-18 1997-01-06 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤

Publications (3)

Publication Number Publication Date
JPH10152471A JPH10152471A (ja) 1998-06-09
JPH10152471A5 JPH10152471A5 (enExample) 2004-12-09
JP4150435B2 true JP4150435B2 (ja) 2008-09-17

Family

ID=27279684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP01205697A Expired - Fee Related JP4150435B2 (ja) 1996-04-18 1997-01-06 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤

Country Status (8)

Country Link
US (1) US5814634A (enExample)
EP (1) EP0802196B1 (enExample)
JP (1) JP4150435B2 (enExample)
KR (1) KR19980069747A (enExample)
AT (1) ATE204867T1 (enExample)
CA (1) CA2202958A1 (enExample)
DE (1) DE69706355T2 (enExample)
TW (1) TW399044B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1131290B1 (en) * 1998-11-20 2008-02-20 F. Hoffmann-La Roche Ag Piperidine ccr-3 receptor antagonists
CA2371728C (en) * 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
WO2002062398A2 (en) 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates
WO2003051403A1 (en) 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
CN103012318B (zh) * 2012-11-25 2014-12-10 大理学院 氟苄基取代哌嗪类化合物及其制备和医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01168678A (ja) * 1987-12-24 1989-07-04 Teikoku Chem Ind Corp Ltd ベンズアミド誘導体
JP2700910B2 (ja) * 1989-02-07 1998-01-21 帝国化学産業株式会社 ベンズアミド誘導体
JP2843871B2 (ja) * 1990-05-14 1999-01-06 本田技研工業株式会社 内燃エンジンの燃焼異常検出装置
JPH05239005A (ja) * 1992-02-28 1993-09-17 Kitsuen Kagaku Kenkyu Zaidan Ｎ−（２−アミノエチル）ベンズアミド類およびその新規中間体
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici

Also Published As

Publication number Publication date
KR19980069747A (ko) 1998-10-26
AU1898797A (en) 1997-10-23
TW399044B (en) 2000-07-21
DE69706355D1 (de) 2001-10-04
US5814634A (en) 1998-09-29
ATE204867T1 (de) 2001-09-15
CA2202958A1 (en) 1997-10-18
EP0802196A1 (en) 1997-10-22
AU711954B2 (en) 1999-10-28
EP0802196B1 (en) 2001-08-29
DE69706355T2 (de) 2002-06-13
JPH10152471A (ja) 1998-06-09

Similar Documents

Publication Publication Date Title
JP4150435B2 (ja) アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
JP3933244B2 (ja) アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
JP4090087B2 (ja) ベンズアミド誘導体及び抗潰瘍剤、抗菌剤
JP4113602B2 (ja) ピロリジン誘導体及び抗潰瘍剤、抗菌剤
JP4058129B2 (ja) ピリジン誘導体及び抗潰瘍剤、抗菌剤
EP0735031B1 (en) N-acetylpiperazine derivative, antibacterial drug, and anti-ulcer drug
EP0282077B1 (en) Pyridyloxy derivatives
JP3690831B2 (ja) インドール含有スルホンアミド誘導体
JP4189043B2 (ja) Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤
JP2661892B2 (ja) Ｎ−アリールアルキルフェニルアセトアミド化合物
JP3093280B2 (ja) フェニルアセトアミド誘導体
JP2004217602A (ja) 抗ヘリコバクター・ピロリ活性を有するアズレン誘導体及びその製造方法並びにそれを含有する薬剤
WO2007077876A1 (ja) 新規トリハロメチオニン誘導体及びそれを含む医薬
HU203872B (en) Process for producing amides of acrylic acid and their salts and pharmaceutical compositions containing them
JPH09249656A (ja) チアジアゾールアミド誘導体及び抗潰瘍剤

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070911

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071030

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080603

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080630

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110704

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees